Chronic Heart Failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: the erolled people who can understand the inormation and explanation from the docotors engaged in the present study CHF Group 1.Prior hospitalization due to CHF and more than and NYHA2 2.LVEF more than and 45% based on 2D echocardiogram Control Group 1.NYHA1 or asymptomatic 2.no organic heart disease
Exclusion criteria
Exclusion criteria: 1. those with unconsiousness status 2. those with severe neurological deficits and pulmonary diseases 3. patients who can not perform FMD 4. patients who can not get Informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of FMD(Flow -Mediated Dilation) in patients with heart failure before and post-3-6 month by using ASV | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of acute effects on FMD between control and CHF Group by using ASV | — |
Countries
Japan
Contacts
Hokkaido University Graduate School of Medicine Department of Cardiovascular Medicine